Trudeau announces purchase of 20 million doses of Oxford University COVID-19 vaccine
Canada has made an additional pre-purchase of COVID-19 vaccine doses, this time securing 20 million doses from Oxford University’s candidate. It is widely seen as one of the most promising candidates currently in phase 3 trial and is being manufactured by AstraZeneca. Canada has now obtained commitments for more than 150 million doses across six different manufacturers, although delivery of the vaccines is contingent on success in human clinical trials and regulatory approval.
Published: September 25, 2020
National PostRead Article